Poplar Therapeutics is a clinical-stage immunology company developing a new class of anti-IgE therapy to challenge convention in allergic disease treatment. Its lead program, PHB-050, is a next-generation anti-IgE antibody with a unique triple-action design currently being studied in atopic diseases... Read more
Org chart
This company has no org chart yet
Teams
This company has no teams yet
Offices
This company has no offices yet
